Table 1.
Eligibility criteria of FAB-HCC study.
Fig 1.
SPIRIT schedule of enrollment. a12-lead echocardiography (ECG) during screening and on Day 1.
Further ECGs should be performed upon clinical suspicion. bAt week 1, week 2, and week 3. cRepetitive pregnancy assessment in women with childbearing potential. dEvery 4th cycle. eEvery other visit (odd cycles).
Fig 2.
(original figure, no copyright permission required, created with BioRender.com), Abbreviations: A/B, atezolizumab plus bevacizumab; CT, computed tomography; FMT, fecal microbiota transplant; HCC, hepatocellular carcinoma; IT, immunotherapy; mRECIST, modified Response Evaluation Criteria in Solid Tumors; RECISTv1.1, Response Evaluation Criteria in Solid Tumors version 1.1.
Table 2.
Donor-specific exclusion criteria.
Table 3.
Targets and tests for processed donor stool analyses.
Table 4.
List of adverse events of special interest (AESIs).